Anoro Ellipta Interactions
There are 501 drugs known to interact with Anoro Ellipta (umeclidinium/vilanterol), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 18 are major, 464 are moderate, and 19 are minor.
- View all 501 medications that may interact with Anoro Ellipta
- View Anoro Ellipta alcohol/food interactions (2)
- View Anoro Ellipta disease interactions (7)
Most frequently checked interactions
View interaction reports for Anoro Ellipta (umeclidinium / vilanterol) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- carvedilol
- Eliquis (apixaban)
- famotidine
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- montelukast
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- ProAir HFA (albuterol)
- rosuvastatin
- tamsulosin
- tramadol
- trazodone
- Ventolin HFA (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Anoro Ellipta alcohol/food interactions
There are 2 alcohol/food interactions with Anoro Ellipta (umeclidinium / vilanterol).
Anoro Ellipta disease interactions
There are 7 disease interactions with Anoro Ellipta (umeclidinium / vilanterol) which include:
- milk protein allergies
- cardiovascular
- diabetes
- hypokalemia
- seizures
- anticholinergic effects
- severe liver impairment
Report options
More about Anoro Ellipta (umeclidinium / vilanterol)
- Anoro Ellipta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (69)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: bronchodilator combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.